[2] [4] In the MHRA-approved product information, diarrhoea is categorised as a 'very common' side effect for both medications, meaning it affects more than 1 in 10 people taking the treatment
The intake does not include a dedicated eating-disorder screen , a substance-use or alcohol screen, a validated PHQ-2 or PHQ-9 depression instrument (the suicidal-ideation question is present but bundled into the GI conditions list rather than getting its own safety context), an allergy screen, a current medications review, a diet or exercise history , a blood pressure reading , or an explicit pregnancy check
Atualmente, a evoluo dessas terapias trouxe opes como a semaglutida, que variam em potncia e frequncia de administrao, permitindo uma personalizao do tratamento de acordo com a necessidade clnica
Safety and Legitimacy: Verify the providers adherence to medical regulations and make sure they use licensed healthcare professionals